Evaluation of cytomegalovirus-specific T-cell reconstitution in patients after various allogeneic haematopoietic stem cell transplantation using interferon-γ-enzyme-linked immunospot and human leucocyte antigen tetramer assays with an immunodominant T-cell epitope

British Journal of Haematology

Volumn 131, Issue 4, 2005, Pages 472-479

  Ohnishi, Mutsuko ^a,b,c   Sakurai, Toshiharu ^a   Heike, Yuji ^b   Yamazaki, Rie ^a   Kanda, Yoshinobu ^d   Takaue, Yoichi ^b   Mizoguchi, Hideaki ^c   Kawakami, Yutaka ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Cytomegalovirus; Haematopoietic stem cell transplantation; Human leucocyte antigen tetramer; Interferon enzyme linked immunospot; Reduced intensity transplantation

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; EPITOPE; FLUDARABINE; GAMMA INTERFERON; HLA A ANTIGEN; HLA ANTIGEN; METHOTREXATE; STEROID; TETRAMER; THYMOCYTE ANTIBODY; VIRUS PROTEIN; CYTOMEGALOVIRUS MATRIX PROTEIN 65KDA; HLA A*0201 ANTIGEN; HLA-A*0201 ANTIGEN; MATRIX PROTEIN; PHOSPHOPROTEIN; VIRUS ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANEMIA; ANIMAL CELL; ARTICLE; CELL FUNCTION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSPOT ASSAY; EVALUATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOASSAY; INTERMETHOD COMPARISON; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; SCHOOL CHILD; SOLID TUMOR; T LYMPHOCYTE; VIRUS REACTIVATION; WHOLE BODY RADIATION; BIOSYNTHESIS; BLOOD; CELLULAR IMMUNITY; CHILD; CYTOMEGALIC INCLUSION BODY DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PHYSIOLOGY; VIRUS ACTIVATION;

ADOLESCENT; ADULT; AGED; ANTIGENS, VIRAL; CHILD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, T-LYMPHOCYTE; FEMALE; HLA-A ANTIGENS; HUMANS; IMMUNITY, CELLULAR; IMMUNODOMINANT EPITOPES; INTERFERON TYPE II; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PHOSPHOPROTEINS; T-LYMPHOCYTES; VIRAL MATRIX PROTEINS; VIRUS ACTIVATION;

EID: 33644791359     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05800.x     Document Type: Article

References (30)

1. Altman J.D. Moss P.A. Goulder P.J. Barouch D.H. McHeyzer-Williams M.G. Bell J.I. McMichael A.J. Davis M.M. ( 1996) Phenotypic analysis of antigen-specific T lymphocytes. Science, 274, 94 96.
2. Boeckh M. Leisenring W. Riddell S.R. Bowden R.A. Huang M.L. Myerson D. Stevens-Ayers T. Flowers M.E. Cunningham T. Corey L. ( 2003) Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood, 101, 407 414.
3. Chakrabarti S. Mackinnon S. Chopra R. Kottaridis P.D. Peggs K. O'Gorman P. Chakraverty R. Marshall T. Osman H. Mahendra P. Craddock C. Waldmann H. Hale G. Fegan C.D. Yong K. Goldstone A.H. Linch D.C. Milligan D.W. ( 2002) High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution. Blood, 99, 4357 4363.
4. Cwynarski K. Ainsworth J. Cobbold M. Wagner S. Mahendra P. Apperley J. Goldman J. Craddock C. Moss P.A. ( 2001) Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. Blood, 97, 1232 1240.
5. Einsele H. Ehninger G. Hebart H. Wittkowski K.M. Schuler U. Jahn G. Mackes P. Herter M. Klingebiel T. Loffler J. Wagner S. Muller C.A. ( 1995) Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood, 86, 2815 2820.
6. Einsele H. Roosnek E. Rufer N. Sinzger C. Riegler S. Loffler J. Grigoleit U. Moris A. Rammensee H.G. Kanz L. Kleihauer A. Frank F. Jahn G. Hebart H. ( 2002) Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood, 99, 3916 3922.
7. Goepfert P.A. Bansal A. Edwards B.H. Ritter Jr., G.D. Tellez I. McPherson S.A. Sabbaj S. Mulligan M.J. ( 2000) A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon. Journal of Virology, 74, 10249 10255.
8. Gondo H. Minematsu T. Harada M. Akashi K. Hayashi S. Taniguchi S. Yamasaki K. Shibuya T. Takamatsu Y. Teshima T. Eto T. Nagafuji K. Mizuno S. Hosoda K. Mori R. Minamishima Y. Niho Y. ( 1994) Cytomegalovirus (CMV) antigenaemia for rapid diagnosis and monitoring of CMV-associated disease after bone marrow transplantation. British Journal of Haematology, 86, 130 137.
9. Gratama J.W. van Esser J.W. Lamers C.H. Tournay C. Lowenberg B. Bolhuis R.L. Cornelissen J.J. ( 2001) Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood, 98, 1358 1364.
10. Hebart H. Rauser G. Stevanovic S. Haenle C. Nussbaum A.K. Meisner C. Bissinger A.L. Tenzer S. Jahn G. Loeffler J. Rammensee H.G. Schild H. Einsele H. ( 2003) A CTL epitope from human cytomegalovirus IE1 defined by combining prediction of HLA binding and proteasomal processing is the target of dominant immune responses in patients after allogeneic stem cell transplantation. Experimental Hematology, 31, 966 973.
11. Junghanss C. Boeckh M. Carter R.A. Sandmaier B.M. Maris M.B. Maloney D.G. Chauncey T. McSweeney P.A. Little M.T. Corey L. Storb R. ( 2002) Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study. Blood, 99, 1978 1985.
12. Kanda Y. Mineishi S. Nakai K. Saito T. Tanosaki R. Takaue Y. ( 2001) Frequent detection of rising cytomegalovirus antigenaemia after allogeneic stem cell transplantation following a regimen containing antithymocyte globulin. Blood, 97, 3676 3677.
13. Kanda Y. Mineishi S. Saito T. Saito A. Ohnishi M. Niiya H. Chizuka A. Nakai K. Takeuchi T. Matsubara H. Makimoto A. Tanosaki R. Kunitoh H. Tobinai K. Takaue Y. ( 2002) Response-oriented preemptive therapy against cytomegalovirus disease with low-dose ganciclovir: a prospective evaluation. Transplantation, 73, 568 572.
14. Kawakami Y. Eliyahu S. Delgado C.H. Robbins P.F. Sakaguchi K. Appella E. Yannelli J.R. Adema G.J. Miki T. Rosenberg S.A. ( 1994) Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proceedings of the National Academy of Sciences of the United States of America, 91, 6458 6462.
15. Kuwana M. Okazaki Y. Kaburaki J. Ikeda Y. ( 2003) Detection of circulating B cells secreting platelet-specific autoantibody is useful in the diagnosis of autoimmune thrombocytopenia. American Journal of Medicine, 114, 322 325.
16. Kuzushima K. Hayashi N. Kimura H. Tsurumi T. ( 2001) Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8(+) T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay. Blood, 98, 1872 1881.
17. Li C.R. Greenberg P.D. Gilbert M.J. Goodrich J.M. Riddell S.R. ( 1994) Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood, 83, 1971 1979.
18. Maris M. Boeckh M. Storer B. Dawson M. White K. Keng M. Sandmaier B. Maloney D. Storb R. Storek J. ( 2003) Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning. Experimental Hematology, 31, 941 952.
19. Mohty M. Faucher C. Vey N. Stoppa A.M. Viret F. Chabbert I. Chabannon C. Bouabdallah R. Ladaique P. Collet L. Zandotti C. Maraninchi D. Blaise D. ( 2000) High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation. Bone Marrow Transplantation, 26, 251 255.
20. Mohty M. Mohty A.M. Blaise D. Faucher C. Bilger K. Isnardon D. Sainty D. Gastaut J.A. Viens P. Olive D. Gaugler B. ( 2004) Cytomegalovirus-specific immune recovery following allogeneic HLA-identical sibling transplantation with reduced-intensity preparative regimen. Bone Marrow Transplantation, 33, 839 846.
21. Nakai K. Kanda Y. Mineishi S. Saito T. Ohnishi M. Niiya H. Chizuka A. Takeuchi T. Matsubara H. Kami M. Makimoto A. Tanosaki R. Kunitoh H. Tobinai K. Takaue Y. ( 2002) Suspected delayed immune recovery against cytomegalovirus after reduced-intensity stem cell transplantation using anti-thymocyte globulin. Bone Marrow Transplantation, 29, 237 241.
22. Nichols W.G. Corey L. Gooley T. Drew W.L. Miner R. Huang M. Davis C. Boeckh M. ( 2001) Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes. Blood, 97, 867 874.
23. Ozdemir E. St John L.S. Gillespie G. Rowland-Jones S. Champlin R.E. Molldrem J.J. Komanduri K.V. ( 2002) Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells. Blood, 100, 3690 3697.
24. Peggs K.S. Verfuerth S. Pizzey A. Khan N. Guiver M. Moss P.A. Mackinnon S. ( 2003) Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines. Lancet, 362, 1375 1377.
25. Reusser P. Riddell S.R. Meyers J.D. Greenberg P.D. ( 1991) Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood, 78, 1373 1380.
26. Sallusto F. Lenig D. Forster R. Lipp M. Lanzavecchia A. ( 1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature, 401, 708 712.
27. Solache A. Morgan C.L. Dodi A.I. Morte C. Scott I. Baboonian C. Zal B. Goldman J. Grundy J.E. Madrigal J.A. ( 1999) Identification of three HLA-A*0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus. Journal of Immunology, 163, 5512 5518.
28. Sun Y. Iglesias E. Samri A. Kamkamidze G. Decoville T. Carcelain G. Autran B. ( 2003) A systematic comparison of methods to measure HIV-1 specific CD8 T cells. Journal of Immunological Methods, 272, 23 34.
29. Tokunaga K. Ishikawa Y. Ogawa A. Wang H. Mitsunaga S. Moriyama S. Lin L. Bannai M. Watanabe Y. Kashiwase K. Tanaka H. Akaza T. Tadokoro K. Juji T. ( 1997) Sequence-based association analysis of HLA class I and II alleles in Japanese supports conservation of common haplotypes. Immunogenetics, 46, 199 205.
30. Walter E.A. Greenberg P.D. Gilbert M.J. Finch R.J. Watanabe K.S. Thomas E.D. Riddell S.R. ( 1995) Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. New England Journal of Medicine, 333, 1038 1044.